Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15824 | 690 | 25.9 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
1684 | 2 | METHOTREXATE//FOLATE RECEPTOR//REDUCED FOLATE CARRIER | 6769 |
15824 | 1 | HIGH DOSE METHOTREXATE//7 HYDROXYMETHOTREXATE//METHOTREXATE | 690 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HIGH DOSE METHOTREXATE | authKW | 664077 | 6% | 34% | 44 |
2 | 7 HYDROXYMETHOTREXATE | authKW | 592761 | 3% | 56% | 24 |
3 | METHOTREXATE | authKW | 421710 | 33% | 4% | 225 |
4 | GLUCARPIDASE | authKW | 402297 | 1% | 91% | 10 |
5 | CARBOXYPEPTIDASE G2 | authKW | 262819 | 2% | 42% | 14 |
6 | METHOTREXATE TOXICITY | authKW | 158033 | 1% | 36% | 10 |
7 | 2 4 DIAMINO N 10 METHYLPTEROIC ACID | authKW | 88506 | 0% | 100% | 2 |
8 | DAMPA | authKW | 88506 | 0% | 100% | 2 |
9 | ELIMINATION DELAY | authKW | 88506 | 0% | 100% | 2 |
10 | LD METHOTREXATE | authKW | 88506 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3639 | 38% | 0% | 263 |
2 | Pharmacology & Pharmacy | 2033 | 33% | 0% | 226 |
3 | Medical Laboratory Technology | 1244 | 7% | 0% | 50 |
4 | Chemistry, Analytical | 1059 | 18% | 0% | 123 |
5 | Hematology | 939 | 12% | 0% | 82 |
6 | Pediatrics | 603 | 11% | 0% | 76 |
7 | Biochemical Research Methods | 289 | 8% | 0% | 53 |
8 | Toxicology | 91 | 4% | 0% | 29 |
9 | Electrochemistry | 37 | 3% | 0% | 18 |
10 | Medicine, Research & Experimental | 11 | 3% | 0% | 19 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARM PHARMACOKINET THER EUT DRUG MONITOR | 88506 | 0% | 100% | 2 |
2 | ANALYT MOL TOXICOL | 44253 | 0% | 100% | 1 |
3 | BIOMED CHEM NEOLEK RUDOLFA WEIGLA 12 | 44253 | 0% | 100% | 1 |
4 | CHEM SCI BIOCHEM DIAGNOST | 44253 | 0% | 100% | 1 |
5 | CHILEAN PEDIAT ONCOL GRP | 44253 | 0% | 100% | 1 |
6 | CHIM VERTE CATALYSE CGCC CCVC | 44253 | 0% | 100% | 1 |
7 | CLIN PHARMACOKINET PHARMACODYNAM SECT | 44253 | 0% | 100% | 1 |
8 | CLIN PHARMACOL ROOM PHARM | 44253 | 0% | 100% | 1 |
9 | CLIN PHARMCOTHER Y | 44253 | 0% | 100% | 1 |
10 | DEPHEMATOL HEMATOONCOL | 44253 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 18224 | 8% | 1% | 55 |
2 | PEDIATRIC HEMATOLOGY AND ONCOLOGY | 10523 | 3% | 1% | 22 |
3 | THERAPEUTIC DRUG MONITORING | 6239 | 3% | 1% | 23 |
4 | CANCER DRUG DELIVERY | 6096 | 1% | 3% | 4 |
5 | JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 5361 | 1% | 2% | 5 |
6 | CANCER TREATMENT REPORTS | 3374 | 2% | 1% | 13 |
7 | PEDIATRIC BLOOD & CANCER | 2485 | 2% | 0% | 16 |
8 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1597 | 3% | 0% | 21 |
9 | RECENT RESULTS IN CANCER RESEARCH | 1343 | 1% | 1% | 4 |
10 | JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 985 | 1% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIGH DOSE METHOTREXATE | 664077 | 6% | 34% | 44 | Search HIGH+DOSE+METHOTREXATE | Search HIGH+DOSE+METHOTREXATE |
2 | 7 HYDROXYMETHOTREXATE | 592761 | 3% | 56% | 24 | Search 7+HYDROXYMETHOTREXATE | Search 7+HYDROXYMETHOTREXATE |
3 | METHOTREXATE | 421710 | 33% | 4% | 225 | Search METHOTREXATE | Search METHOTREXATE |
4 | GLUCARPIDASE | 402297 | 1% | 91% | 10 | Search GLUCARPIDASE | Search GLUCARPIDASE |
5 | CARBOXYPEPTIDASE G2 | 262819 | 2% | 42% | 14 | Search CARBOXYPEPTIDASE+G2 | Search CARBOXYPEPTIDASE+G2 |
6 | METHOTREXATE TOXICITY | 158033 | 1% | 36% | 10 | Search METHOTREXATE+TOXICITY | Search METHOTREXATE+TOXICITY |
7 | 2 4 DIAMINO N 10 METHYLPTEROIC ACID | 88506 | 0% | 100% | 2 | Search 2+4+DIAMINO+N+10+METHYLPTEROIC+ACID | Search 2+4+DIAMINO+N+10+METHYLPTEROIC+ACID |
8 | DAMPA | 88506 | 0% | 100% | 2 | Search DAMPA | Search DAMPA |
9 | ELIMINATION DELAY | 88506 | 0% | 100% | 2 | Search ELIMINATION+DELAY | Search ELIMINATION+DELAY |
10 | LD METHOTREXATE | 88506 | 0% | 100% | 2 | Search LD+METHOTREXATE | Search LD+METHOTREXATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCOTT, JR , ZHOU, YM , CHENG, C , WARD, DA , SWANSON, HD , MOLINELLI, AR , STEWART, CF , NAVID, F , JEHA, S , RELLING, MV , ET AL (2015) COMPARABLE EFFICACY WITH VARYING DOSAGES OF GLUCARPIDASE IN PEDIATRIC ONCOLOGY PATIENTS.PEDIATRIC BLOOD & CANCER. VOL. 62. ISSUE 9. P. 1518 -1522 | 23 | 100% | 2 |
2 | WIDEMANN, BC , ADAMSON, PC , (2006) UNDERSTANDING AND MANAGING METHOTREXATE NEPHROTOXICITY.ONCOLOGIST. VOL. 11. ISSUE 6. P. 694-703 | 30 | 71% | 171 |
3 | SELESOVSKA, R , JANIKOVA-BANDZUCHOVA, L , CHYLKOVA, J , (2015) SENSITIVE VOLTAMMETRIC SENSOR BASED ON BORON-DOPED DIAMOND ELECTRODE FOR DETERMINATION OF THE CHEMOTHERAPEUTIC DRUG METHOTREXATE IN PHARMACEUTICAL AND BIOLOGICAL SAMPLES.ELECTROANALYSIS. VOL. 27. ISSUE 1. P. 42 -51 | 28 | 65% | 5 |
4 | RUBINO, FM , (2001) SEPARATION METHODS FOR METHOTREXATE, ITS STRUCTURAL ANALOGUES AND METABOLITES.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 764. ISSUE 1-2. P. 217 -254 | 58 | 46% | 44 |
5 | PATTERSON, DM , LEE, SM , (2010) GLUCARPIDASE FOLLOWING HIGH-DOSE METHOTREXATE: UPDATE ON DEVELOPMENT.EXPERT OPINION ON BIOLOGICAL THERAPY. VOL. 10. ISSUE 1. P. 105-111 | 27 | 79% | 10 |
6 | WIDEMANN, BC , BALIS, FM , KIM, A , BORON, M , JAYAPRAKASH, N , SHALABI, A , O'BRIEN, M , EBY, M , COLE, DE , MURPHY, RF , ET AL (2010) GLUCARPIDASE, LEUCOVORIN, AND THYMIDINE FOR HIGH-DOSE METHOTREXATE-INDUCED RENAL DYSFUNCTION: CLINICAL AND PHARMACOLOGIC FACTORS AFFECTING OUTCOME.JOURNAL OF CLINICAL ONCOLOGY. VOL. 28. ISSUE 25. P. 3979-3986 | 22 | 92% | 27 |
7 | BLASCO, H , SILLY, S , TOURNAMILLE, JF , GYAN, E , SENECAL, D , ANDRE, V , COLOMBAT, P , LE GUELLEC, C , (2008) THE NEED FOR A BETTER DEFINITION OF THERAPEUTIC INDICATIONS OF CARBOXYPEPTIDASE IN DELAYED ELIMINATION OF METHOTREXATE.THERAPIE. VOL. 63. ISSUE 1. P. 19 -28 | 26 | 87% | 2 |
8 | DOMBROWSKY, E , JAYARAMAN, B , NARAYAN, M , BARRETT, JS , (2011) EVALUATING PERFORMANCE OF A DECISION SUPPORT SYSTEM TO IMPROVE METHOTREXATE PHARMACOTHERAPY IN CHILDREN AND YOUNG ADULTS WITH CANCER.THERAPEUTIC DRUG MONITORING. VOL. 33. ISSUE 1. P. 99-107 | 20 | 95% | 11 |
9 | CHLADKOVA, J , HAK, J , MARTINKOVA, J , CHLADEK, J , (2010) HIGH-DOSE METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: 7-HYDROXYMETHOTREXATE SYSTEMIC EXPOSURE AND URINARY CONCENTRATIONS AT THE STEADY STATE CORRELATE WELL WITH THOSE OF METHOTREXATE.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 60. ISSUE 12. P. 769-775 | 25 | 81% | 0 |
10 | CHRISTENSEN, AM , PAULEY, JL , MOLINELLI, AR , PANETTA, JC , WARD, DA , STEWART, CF , HOFFMAN, JM , HOWARD, SC , PUI, CH , PAPPO, AS , ET AL (2012) RESUMPTION OF HIGH-DOSE METHOTREXATE AFTER ACUTE KIDNEY INJURY AND GLUCARPIDASE USE IN PEDIATRIC ONCOLOGY PATIENTS.CANCER. VOL. 118. ISSUE 17. P. 4321 -4330 | 21 | 84% | 9 |
Classes with closest relation at Level 1 |